ROLKE JAMES (Chief Scientific Officer) received a stock award from LA JOLLA PHARMACEUTICAL CO
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/19/2020ACC: 0000920465-20-000074
Officer· Chief Scientific Officer
Since Aug 2018
+280.00
Net shares
Net buyer
$820.40
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
280.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+140.00
Price / share
$5.86
Trade value
$820.40
% of position
0.2%
5/15/2020
81.43K→81.57K
Total
Net shares
+140.00
Net value
$820.40
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/15/2020 | A · Award | +140.00 | $5.86 | $820.40 | 0.2% | 81.43K | 81.57K |
| Total | +140.00 | $820.40 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
140.00 shares
Shares
+140.00
Strike price
6.89
Held after
140.00
Exercisable
—
5/15/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock140.00 shares | 5/15/2020 | A · Award | +140.00 | 6.89 | — | 140.00 |